Singapore markets closed

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0000+0.0200 (+2.04%)
At close: 04:00PM EDT
0.9810 -0.02 (-1.90%)
After hours: 04:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 60.10M
Enterprise value -84.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.18
Price/book (mrq)0.38
Enterprise value/revenue -13.46
Enterprise value/EBITDA 0.71

Trading information

Stock price history

Beta (5Y monthly) 1.83
52-week change 3-38.65%
S&P500 52-week change 322.36%
52-week high 32.2900
52-week low 30.7310
50-day moving average 31.1386
200-day moving average 31.2478

Share statistics

Avg vol (3-month) 3376.18k
Avg vol (10-day) 3743.52k
Shares outstanding 560.09M
Implied shares outstanding 660.09M
Float 843.75M
% held by insiders 119.58%
% held by institutions 144.66%
Shares short (15 Apr 2024) 4662.73k
Short ratio (15 Apr 2024) 43.47
Short % of float (15 Apr 2024) 41.42%
Short % of shares outstanding (15 Apr 2024) 41.10%
Shares short (prior month 15 Mar 2024) 4667.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-994.36%

Management effectiveness

Return on assets (ttm)-28.83%
Return on equity (ttm)-55.84%

Income statement

Revenue (ttm)6.29M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -115.08M
Net income avi to common (ttm)-112.67M
Diluted EPS (ttm)-1.9500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)173M
Total cash per share (mrq)2.88
Total debt (mrq)28.27M
Total debt/equity (mrq)17.77%
Current ratio (mrq)7.24
Book value per share (mrq)2.70

Cash flow statement

Operating cash flow (ttm)-78.58M
Levered free cash flow (ttm)-43.83M